Skip to content

PLUS THERAPEUTICS, INC.

PSTV

CIK 0001095981

← back to feed
Revenue (TTM)
$2.76M
+36.5% YoY Q1 May 2026
Net Income (TTM)
−$23.62M
−72.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$30.96
+87.6% YoY Q1 May 2026
Gross Margin
14.2%
Q1 May 2026
Operating Margin
-604.4%
Q1 May 2026
Net Margin
-856.1%
Q1 May 2026
Free Cash Flow (TTM)
−$23.67M
Q1 May 2026
Cash
$3.02M
Q1 May 2026
Total Debt
$7.38M
Q1 May 2026
Shares Outstanding
6.88M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings